These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28685026)

  • 1. Cholecystokinin-induced satiety, a key gut servomechanism that is affected by the membrane microenvironment of this receptor.
    Desai AJ; Dong M; Harikumar KG; Miller LJ
    Int J Obes Suppl; 2016 Dec; 6(Suppl 1):S22-S27. PubMed ID: 28685026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a Positive Allosteric Modulator of Cholecystokinin Action at CCK1R in Normal and Elevated Cholesterol.
    Harikumar KG; Coudrat T; Desai AJ; Dong M; Dengler DG; Furness SGB; Christopoulos A; Wootten D; Sergienko EA; Sexton PM; Miller LJ
    Front Endocrinol (Lausanne); 2021; 12():789957. PubMed ID: 34950108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of β-sitosterol on type 1 cholecystokinin receptor dysfunction induced by elevated membrane cholesterol.
    Desai AJ; Dong M; Miller LJ
    Clin Nutr; 2016 Dec; 35(6):1374-1379. PubMed ID: 27016394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A type 1 cholecystokinin receptor mutant that mimics the dysfunction observed for wild type receptor in a high cholesterol environment.
    Desai AJ; Harikumar KG; Miller LJ
    J Biol Chem; 2014 Jun; 289(26):18314-26. PubMed ID: 24825903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target.
    Miller LJ; Desai AJ
    Trends Endocrinol Metab; 2016 Sep; 27(9):609-619. PubMed ID: 27156041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for positive allosteric modulators of cholecystokinin type 1 receptor potentially useful for management of obesity.
    Dengler DG; Sun Q; Harikumar KG; Miller LJ; Sergienko EA
    SLAS Discov; 2022 Oct; 27(7):384-394. PubMed ID: 35850480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fat in the intestine as a regulator of appetite--role of CCK.
    Beglinger C; Degen L
    Physiol Behav; 2004 Dec; 83(4):617-21. PubMed ID: 15621067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor.
    Desai AJ; Mechin I; Nagarajan K; Valant C; Wootten D; Lam PCH; Orry A; Abagyan R; Nair A; Sexton PM; Christopoulos A; Miller LJ
    Mol Pharmacol; 2019 Mar; 95(3):245-259. PubMed ID: 30591538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of a cholecystokinin receptor agonist 'trigger' in an effort to develop positive allosteric modulators without intrinsic agonist activity.
    Desai AJ; Henke BR; Miller LJ
    Bioorg Med Chem Lett; 2015 May; 25(9):1849-55. PubMed ID: 25862198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cholecystokinin secretion by intraluminal releasing factors.
    Liddle RA
    Am J Physiol; 1995 Sep; 269(3 Pt 1):G319-27. PubMed ID: 7573441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin responsiveness varies across the population dependent on metabolic phenotype.
    Desai AJ; Dong M; Langlais BT; Dueck AC; Miller LJ
    Am J Clin Nutr; 2017 Aug; 106(2):447-456. PubMed ID: 28592602
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensing of L-Arginine by Gut-Expressed Calcium Sensing Receptor Stimulates Gut Satiety Hormones Cholecystokinin and Glucose-Dependent Insulinotropic Peptide Secretion in Pig Model.
    Wang C; Kang C; Xian Y; Zhang M; Chen X; Pei M; Zhu W; Hang S
    J Food Sci; 2018 Sep; 83(9):2394-2401. PubMed ID: 30088839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of Cholecystokinin in the Nutritional Continuum. Physiology and Potential Therapeutics.
    Miller LJ; Harikumar KG; Wootten D; Sexton PM
    Front Endocrinol (Lausanne); 2021; 12():684656. PubMed ID: 34149622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in brain cholecystokinin receptors after fasting.
    Saito A; Williams JA; Goldfine ID
    Nature; 1981 Feb; 289(5798):599-600. PubMed ID: 6258086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex.
    Desai AJ; Lam PC; Orry A; Abagyan R; Christopoulos A; Sexton PM; Miller LJ
    J Med Chem; 2015 Dec; 58(24):9562-77. PubMed ID: 26654202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin cells.
    Liddle RA
    Annu Rev Physiol; 1997; 59():221-42. PubMed ID: 9074762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.
    Trevaskis JL; Sun C; Athanacio J; D'Souza L; Samant M; Tatarkiewicz K; Griffin PS; Wittmer C; Wang Y; Teng CH; Forood B; Parkes DG; Roth JD
    Diabetes Obes Metab; 2015 Jan; 17(1):61-73. PubMed ID: 25204356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of Action and Structure-Activity Relationships of Tetracyclic Small Molecules Acting as Universal Positive Allosteric Modulators of the Cholecystokinin Receptor.
    Dengler DG; Harikumar KG; Yen A; Sergienko EA; Miller LJ
    Membranes (Basel); 2023 Jan; 13(2):. PubMed ID: 36837653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated actions of cholecystokinin on the gastrointestinal tract: use of the cholecystokinin bioassay.
    Liddle RA
    Gastroenterol Clin North Am; 1989 Dec; 18(4):735-56. PubMed ID: 2482253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Afferent signals regulating food intake.
    Bray GA
    Proc Nutr Soc; 2000 Aug; 59(3):373-84. PubMed ID: 10997653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.